🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alex H. Gifford

ORCID: 0000-0002-6404-3793
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials”.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00434-9
N/A
3.9DataRank · unranked
127 citations

Félix Ratjen, Renee Russell, Scott H. Donaldson, Kristin A. Riekert, Gregory S. Sawicki +91 more

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00504-5
N/A
1.5DataRank · unranked
67 citations

Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more

Calprotectin-mediated zinc chelation inhibits Pseudomonas aeruginosa protease activity in cystic fibrosis sputum

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.25.432981
N/A
0DataRank · unranked
2 citations

Alex W. Crocker, Alex H. Gifford, Deborah A. Hogan, Danielle M. Vermilyea

Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis

CHEST Journal(2023)10.1016/j.chest.2023.03.043
N/A
0DataRank · unranked
4 citations

Alexandra C. Hinton, Shijing Jia, Samya Z. Nasr, Joel Mermis, Thomas Lahiri +12 more

106 Impact of discontinuing hypertonic saline and dornase alfa in people with cystic fibrosis established on elexacaftor-tezacaftor-ivacaftor: A SIMPLIFY ancillary study

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01041-x
N/A
0DataRank · unranked
1 citations

Alex H. Gifford, Margaret Kloster, Richard Russell, Andrew T. Braun, Ronald L. Gibson +9 more

The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.02.003
N/A
0DataRank · unranked
19 citations

Timothy E. Corcoran, Joseph M. Pilewski, Beth L. Laube, Peter J. Mogayzel, Agathe Ceppe +8 more

Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis

Annals of the American Thoracic Society(2024)10.1513/annalsats.202404-366oc
N/A
0DataRank · unranked
10 citations

Alex H. Gifford, Margaret Kloster, Renee Russell, Andrew T. Braun, Ronald L. Gibson +11 more

Formative evaluation of a dashboard to support coproduction of healthcare services in cystic fibrosis

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.03.009
N/A
0DataRank · unranked
49 citations

Alex H. Gifford, Cynthia Brady, Jordan Dunitz, Madeline Elmhirst, Jonathan Flath +12 more

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.03.002
N/A
0DataRank · unranked
7 citations

Yizhuo Wang, Melissa Ross, Jonathan B. Zuckerman, Susan Murray, MeiLan K. Han +10 more

Serum and Sputum Iron Trends Distinguigh Responders and Non-Responders to Treatment of Cystic Fibrosis Pulmonary Exacerbation

(2020)10.21203/rs.3.rs-52287/v1
N/A
0DataRank · unranked
0 citations

Deepika Polineni, Jianghua He, Jessica D’Amico, Dana B. Dorman, Molly A. Williams +5 more